

The Recombinant Human Fractalkine (CX3CL1) by ABM is E. coli-expressed, 8.9 kDa, 20–100 ng/mL chemoattraction (BaF3/CX3CR1). For neuroinflammation, monocyte trafficking, and chemokine biology research. 20 µg or 1.0 mg. Available in 20 µg (Z101895) and 1.0 mg (Z101899).

